Parteck® SRP 80 by The Life Science business of Merck KGaA, Darmstadt, Germany, operates as MilliporeSigma in the U.S. and Canada
Status:
Reviewer
Member since: 2016
Organization: CONTINUUS Pharmaceuticals
-
- Ease of use
- After sales service
- Value for money
Great excipient for sustained release formulations
Application Area: Pharmaceutical formulations
"We've been testing this excipient in sustained release oral formulations and it seems to work very well. More importantly, it is compatible with a broad range of active pharmaceutical ingredients [salts, acids, bases and neutral species]. It comes with a very thorough C of A and Millipore's technical support has been OUTSTANDING!"
Review date: 01 Aug 2017 | Parteck® SRP 80
Parteck® SRP 80, a functional excipient based on polyvinyl alcohol (PVA), provides reliable sustained drug delivery over long release periods. Its matrix diffusion technology helps increase the efficacy and bioavailability of your compound while reducing side effects and the risk of dose dumping.
Parteck® SRP 80 is well suited for direct compression processes and helps accelerate your formulation work—from simplified feasibility and development to rapid and cost-efficient manufacturing.
Benefits of Parteck® SRP 80:
- Reliable sustained release profiles of active pharmaceutical ingredients over several hours
- Suitable for direct compression processes with conventional equipment
- Resistant to pH- and alcohol-induced dose dumping
- Superior batch-to-batch consistency and robust performance due to fully synthetic material
- Faster time to market with the Emprove® program
Product Overview
Parteck® SRP 80
Manufacturer The Life Science business of Merck KGaA, Darmstadt, Germany, operates as MilliporeSigma in the U.S. and Canada | Available Worldwide
4.7 / 5.0 | 1 reviews
